Title : Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine.

Pub. Date : 2017 May

PMID : 28270046






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine. gemcitabine mucin 4, cell surface associated Homo sapiens
2 BACKGROUND: Previous in vitro studies have shown that mucin 4 (MUC4) confers resistance toward gemcitabine in pancreatic cancer cells. gemcitabine mucin 4, cell surface associated Homo sapiens
3 BACKGROUND: Previous in vitro studies have shown that mucin 4 (MUC4) confers resistance toward gemcitabine in pancreatic cancer cells. gemcitabine mucin 4, cell surface associated Homo sapiens
4 The aim of this study was to evaluate the predictive impact of MUC4 expression on survival in patients with resectable pancreatic cancer receiving adjuvant gemcitabine. gemcitabine mucin 4, cell surface associated Homo sapiens
5 CONCLUSIONS: This is the first study indicating a predictive role of MUC4 expression for gemcitabine treatment in the clinical setting. gemcitabine mucin 4, cell surface associated Homo sapiens